What is Cytarabine-Daunorubicin?
Category: Prescription Drugs
See also: Cytarabine Daunorubicin
This regimen is used to consolidate remission in acute myelogenous leukemia and includes Cytarabine (Ara-C, Cytosar-U) and Daunorubicin (Daunomycin, Cerubidine). The duration varies by protocol.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Acute myeloid leukemia | 28 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Why patients stopped taking Cytarabine-Daunorubicin
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 1 |
Duration
Stopped taking Cytarabine-Daunorubicin
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 |
Last updated: